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The  ability of  guinea pigs to  respond immunologically to poly-L-lysine (PLL),  i 
to a random copolymer of L-glutamic acid and L-lysine (GL), and to hapten conjugates 
of these materials is largely determined by the presence of a  single autosomal domi- 
nant "immune response gene," designated the PLL gene. Inbred strain 2 guinea  pigs 
are homozygous for the PLL gene, whereas inbred strain 13  guinea pigs lack the gene. 
A  varying proportion of commercially available random bred Hartley strain guinea 
pigs possess the PLL gene. Animals homozygous or heterozygous for  the PLL gene 
are termed "responders" and animals lacking the gene, "nonresponders," with respect 
to immunization with either PLL or GL hapten conjugates (1-4). 
In a recent study (2)<  13)F1 responder guinea pigs were backcrossed with strain 13 
nonresponder animals and the progeny tested for both their inheritance of the PLL 
gene and the genes determining the expression of major strain 2  histocompatibility 
antigens. A cytotoxic strain 13 antistrain 2 isoantiserum capable of causing significant 
lysis of ~Cr-labeled (2  X  13)Fi lymphocytes was  employed in this study. All nine 
backcross guinea pigs inheriting the PLL gene from the (2  >( 13)F1 parent were shown 
to have also inherited the strain 2 histocompatibility antigens recognized by the iso- 
antiserum. These histocompatibility antigens were lacking in eight backcross progeny 
not possessing the PLL gene. Further, in mixed lymphocyte reactions, only lympho- 
cytes from  PLL responder backcross guinea pigs were capable of stimulating DNA 
synthesis in strain 13 lymphocytes (5). These findings indicated that the PLL gene 
was "linked" to a  locus controlling a  major histocompatibility antigen. They paral- 
leled the  earlier observation of  McDevitt  and  Chinitz  that  in  mice,  the  "specific 
immune response locus," IR-1, is linked to the H~ histocompatibility locus (6). 
These results are equally consistent with the notion that, rather  than just being 
linked to, the immune response genes are in fact identical with genes coding for certain 
histocompatibility antigens (7). If this were so, outbred animals possessing a particular 
immune response gene should express a common histocompatibility antigen. Further, 
this particular antigen should not be present on tissues of nonresponder animals. Thus, 
in guinea pigs, cells from all Hartley strain responder animals should have a  histo- 
• 1 Abbreviations used  in  this paper: PLL,  poly-L-lysine; GL,  random  copolymer  of L- 
glutamic acid and L-lysine; DNP-PLL, 2,4-dinitrophenyl-PLL. NIH, National Institutes of 
Health. 
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compatibility antigen in common with strain 2 animals and this antigen should be ab- 
sent from cells of all nonresponder guinea pigs. The following experiments were per- 
formed to investigate this possibility. 
Materials and Methods 
Experimental Animals.--55 Harfley strain guinea pigs were obtained from either the Na- 
tional Institutes of Health (NIH)  Animal  Production Unit (33  animals)  or CAMM Animal 
Research Laboratory, Wayne, N.  J.  (22  animals). 10 NIH Multipurpose and  5  Abyssinian 
strain guinea pigs (gift of Dr. J. Battisto) were also included in this study. Strains 2 and 13 
guinea pigs were obtained from the NIH Animal Production Unit; these animals were mated 
to produce (2 X  13)F1 hybrid animals. 
Materials.--A poly-L-lysine HBr preparation with 110,000 avg tool wt was purchased from 
Pilot Chemicals,  Inc., Watertown, Mass. The PLL was reacted with 2,4-dinitrofluorobenzene 
as described (1) and 2,4-dlnitrophenyl-PLL (DN-P12 PLL) was prepared. The subscript refers 
to the number of DNP groups per molecule. Complete Freund's adjuvant was obtained from 
Difco Laboratories, Detroit, Mich. and contained 0.5 mg/ml Micrococcus butyricum. ~lCr, 185 
~Ci/~g, was obtained from Amersham-Searle, Chicago,  Ill. Fetal calf serum was purchased 
from North American Biologicals, Inc., Miami, Fla. Lyophilized guinea pig serum, as a source 
of complement, was purchased from Baltimore Biological  Laboratories, Cockeysville,  Md. 
Goat anti-rabbit gamma globulin was obtained from Dr. Rose Mage and was conjugated with 
fluorescein  isothiocyanate as previously described (8). 
Identification of Guinea Pigs Possessing the PLL Gene.--All guinea  pigs were tested for the 
presence of the PLL gene by their response to immunization with DNP-PLL as described 
elsewhere (1). 28 Hartley animals responded to this immunization with both delayed hyper- 
sensitivity and the production of high amounts of anti-DNP antibody; they were thus shown 
to possess the PLL gene. The remaining 27 Hartley stlain guinea pigs and all the NII-I Multi- 
purpose and Abyssinian strain animals tested failed to make such a response. 
Preparation of Isoanliserum against Histocompatibility Antigens of Strain  2 and Strain  13 
Guinea Pigs.--Lung,  liver,  spleen,  and  lymph node tissues from strain 2  guinea pigs were 
gently ground in a glass hand homogenizer with twice their volume of saline.  The tissue sus- 
pension was emulsified with complete Freund's adjuvant and a strain 13 guinea pig was im- 
munized with 0.2 ml of the emulsion in each footpad. The animal was then injected every wk 
for 10 wk with 1 ml of the strain 2 tissue mixture in saline, divided into five intradermal doses. 
The guinea pig was bled weekly for a month and these sera pooled (batch A). The animal was 
bled again 1 wk later (batch B). 
A Hartley guinea pig was similarly immunized with strain 13 mixed-tissue homogenates to 
produce an anti-strain 13 isoantiserum. The antiserum was absorbed with strain 2 lymphocytes 
to remove antibodies cross-reactive  with strain 2 histoeompatibility antigens. 
Detection of Strain  2 Histocompatibility Antigens  by  5lCr Cytotoxicity Test.--Inguinal  and 
popliteal lymph nodes were removed from the guinea pigs and gently teased over a 80 gauge 
mesh stainless steel sieve to yield single cell suspensions. The medium used throughout was 
Hanks' balanced salt solution supplemented with 10% fetal calf serum. The cells were washed 
once and resuspended to a concentration of 5 X  107 cells per ml. 50/~Ci of ~lCr per ml were 
added to each of the cell suspensions and the mixtures were incubated at 37°C for 30 rain. 
The cells were then washed four times at 4°C and finally resuspended to a concentration of 
107 cells per ml. A volume of 0.1 ml of cell suspension was added to 0.1 ml of diluted isoanti- 
serum. Unless otherwise stated the dilution of the isoantiserum was 1:5. After 15 rain at room 
temperature, 0.1  ml of a  1:2 dilution of reconstituted lyophilized guinea pig serum, pH 7.2, 
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further 2 hr and 2 ml of medium were then added. The tubes were centrifuged and a 0.2 ml 
sample was measured and compared with the radioactivity present in an equal volume of the 
supernatants from  tubes containing cells incubated in medium plus complement only,  and 
with that present in tubes containing cells which were frozen and thawed four times. The per- 
centage of maximum  51Cr released specifically from the lymphoeytes of each guinea pig was 
calculated as follows: 
Radioactivity released by antiserum dilution 
--Radioactivity released in absence of antiserum 
X  100 
Radioactivity released by frozen-thawed cells 
--Radioactivity released in absence of antiserum 
Each cell suspension was tested in quadruplicate. 
TABLE  I 
Percentage of Maximum 51 Cr Release from Guinea Pig Lymphocytes  Exposed  to a 1:5 Dilution 
of Strain 13 Anti-Strain 2 Isoantiserum  in the Presence of Complement 
PLL responder  PLL nonresponder 
Batch of isoantiserum  (2 X  13)F1  Hartley*  Hartley*  NIH  Multipurpose  Abyssinian 
A 
B 
Total No. of Ani- 
mals and mean 
%  max. rel. 
No. of  %_4_  s~ 






No. of  %4- SE 
animals max. rel. 
Z-  48.--7 
±2.9 
23  14.7 
/  ±1.2 
28  20.7 
No. of  % 
animals  max.  rel. 
8  0.6 
19  0.0 
27  0.2 
an °a°,fs 
10  0.3 
10  0.3 
No. of  % 
ani-  max. 
reals  rel. 
5  0.0 
5  0.0 
* 18  responder and  14  nonresponder Hartley strain  animals were  obtained from  NIH, 
while 10 responder and  13 nonresponder animals were obtained from CAMM  Animal Re- 
search Laboratory. 
Strain  2 Hepatoma  Cell Preparation.--Strain  2 hepatoma cells,  propagated in the ascites 
form, were obtained through the courtesy of Dr. Stanley Wepsic, National Institutes of Health, 
Bethesda, Md. The origin and properties of these cells have been described previously (9). 
Determination  of  the  Percentage  of  Lymphocyte  Contamination  within  the  Hepatoma  Cell 
Preparatlon.--The hepatoma cell preparation used in the absorption study was washed twice 
with Eagle's medium containing 1% normal rabbit serum. A guinea pig lymph node cell sus- 
pension was also prepared. Both cell types were smeared onto glass slides, fixed in 95% alcohol, 
and air-dried. The slides were washed in phosphate buffered saline and exposed  to a  1:50 
dilution of rabbit anti-guinea pig lymphocyte serum,  the preparation and characteristics of 
which have been described previously (10).  The slides were left at room temperature for 30 
rain, washed, and exposed to fluoresceinated goat anti-rabbit globulin solution for a  further 
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cells in both the hepatoma ascites fluid smear and normal lymph node cell smears were ex- 
amined. The percentages of cells showing bright fluorescence at their periphery were deter- 
mined. To vindicate this technique, known numbers of lymphocytes were added to the hepa- 
toma cell preparation. The added lymphocytes could be detected with a high degree of ac- 
curacy within the hepatoma cell preparation. 
RESULTS 
Lymph  node  lymphocytes from PLL  responder  and  nonresponder  guinea 
pigs were tested for the  presence of the  histocompatibility  antigen(s)  recog- 
nized by strain 13 anti-strain 2 isoantiserum using the  51Cr release cytoxicity 
assay method  (Table I).  Significant  51Cr release was observed from lympho- 
cytes  of  all  animals  possessing  the PLL  gene,  whereas  no  significant  5~Cr- 
release occurred from lymphocytes from nonresponder  guinea pigs. The per- 
centage  of  lysis  observed with  cells  from responder  Hartley  strain  animals 
was slightly less than that achieved when the same dilution of the isoantisera 
were tested against lymphocytes from (2 X  13)F1 animals. 
The question must be considered whether the antigen(s) common to Hartley 
responder and  strain  2  guinea  pigs,  detected  by the  isoantisera  used  in  this 
study,  was  (were)  restricted  to lymphocytes or  represented  a  general  tissue 
histocompatibility antigen. We therefore investigated if the antigen was present 
on  nonlymphoid  ceils.  It  was  not  detected  on  erythrocytes  since  strain  2 
erythrocytes  were  not  agglutinated  by  the  isoantiserum.  It  was,  however, 
apparently present  on strain  2  ascites hepatoma cells. Thus when 0.I  ml of 
the isoantiserum  (batch A) was incubated with 50  ×  106 hepatoma cells for 
60  rain  at  37°C,  significant  reduction  in  lyric  activity  against  51Cr-labeled 
lymphocytes from both  (2  X  13)F1 and Hartley responder animals occnrred 
(Fig. 1 a, b). This absorption was specific for strain 2 antigen since comparable 
exposure of an anti-strain  13 isoantiserum to strain 2 hepatoma cells did not 
reduce its lyric activity against (2  ×  13)Ft cells (Fig.  1 c). In further experi- 
ments, to determine whether the lyric activity could be completely absorbed 
from the  anti-strain  2  isoantiserum,  a  1:10 dilution  of the isoantiserum was 
exposed to varying numbers of either strain 2 lymphocytes or strain 2 hepa- 
toma cells  for 60 rain  at  37°C.  The  remaining  activity  against  (2  X  13)F1 
cells was determined and compared with that of the unabsorbed sera. As shown 
in Fig. 2, complete absorption was achieved by either 9  ×  107 hepatoma ceils 
or  4.5  )<  106  banphocytes.  The  level  of  lymphocyte  contamination  in  the 
hepatoma  cell  preparation  was  determined  using  a  rabbit  anti-guinea  pig- 
lymphocytes serum  followed by exposure to fluoresceinated goat  anti-rabbit 
FIG. 1.  Percentage of maximum 51Cr release achieved by varying dilutions of either anti- 
strain 2 or anti-strain 13 isoanfiserum, absorbed (© ..... O) or not absorbed (O--Q)  with 
50 X  106 hepatoma cells, and tested against lymphocytes from either (2 X  13)F1 or Harfley 
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globulin. The percentage of contamination was found to be 0.5 %  (Table II). 
Therefore contaminating lymphocytes could not explain the capacity of the 
hepatoma cell preparation  to absorb anti-strain 2 histocompatibility activity 
from the isoantiserum. 
DISCUSSION 
The data presented demonstrate that an antiserum prepared in a strain 13 
guinea pig  against strain 2 histocompatibility antigens is able to detect the 
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FIc. 2.  Percentage of remaining lytic activity of anti-strain 2 isoantiserum absorbed with 
varying numbers of strain 2 lymphocytes or hepatoma cells. 
TABLE  II 
Percentage of Cells Staining with Fluoresceinated Goat Anti-Rabbit Globulin Solution~ Following 
Exposure to Rabbit Anti-Guinea Pig Lymphocyte Serum 
Source of cells  Percentage of ceils stained 
Lymph node  89% 
Hepatoma-induced  ascites  0.5% 
PLL responder  guinea pigs  in  a  population  of random bred Hartley strain 
guinea pigs. Thus only lymphocytes from Hartley responder guinea pigs were 
lysed when exposed to a strain 13 anti-strain 2 isoantiserum. It can therefore 
be  concluded that  Hartley guinea pigs  with  the  PLL  gene possess  a  histo- 
compatibility antigen which is either idential, or strongly cross-reacting with, 
a  major strain  2 histocompatibility antigen. It  is further concluded that  al- 
though the  antigen is found in  a  higher concentration on ba'nphocytes it  is 
Mso present on hepatoma cells  and therefore probably  represents  a  general 
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Although  strain  2  and  Hartley  responder  guinea  pigs  share  at  least  one 
histocompatibility antigen they are not histocompatible. Thus an inoculum of 
2  )<  106 strain  2  leukemia cells  (11)  that was  uniformly lethal for strain  2 
and  (2  X  13)F1  guinea  pigs  failed to  kill  Hartley  responder guinea  pigs.  2 
Further, antisera cytotoxic to strain 2 lymphocytes could be raised in a Hartley 
responder  recipient  even  though  these  animals  share  a  common histocom- 
patibility  antigen.  The anti-strain  2  isoantisera  raised  in  Hartley responder 
guinea pigs showed considerable cross-reaction against strain 13 lymphocytes.  ~ 
These  findings  were  expected  since  there  has  been  no  known  relationship 
between strain 2 inbred guinea pigs and the outbred Hartley animals, whereas 
strain 2 and strain 13 are related in that a single male guinea pig was used to 
initiate both strains (footnote 3 and reference 12). 
The persistent  association between  responder status  and  a  histocompati- 
bility antigen in both ([2)<  13] )< 13) backcrossed and outbred Hartley strain 
guinea  pigs,  strongly  suggests  that  a  single  genetic  locus  determines  both 
characteristics. Thus,  if two closely linked loci had accounted for the results 
observed with  the  backcrossed  animals,  one would have expected "crossing 
over" to have occasionally occurred during the random matings among Hartley 
strain animals over the many years these animals have been bred. No evidence 
of such a  crossing over was observed in a  sample of 55 Hartley animals ob- 
tained from two different breeders. Our findings therefore seem to implicate 
histocompatibility antigens as important determinants of immune responsive- 
ness. The mechanism by which they convey immune responsiveness remains 
to be determined. 
SUMMARY 
Outbred Hartley strain guinea pigs capable of responding immunologically 
to 2,4-dinitrophenylated poly-L-lysine were shown to display a  histocompati- 
bility specificity in common with inbred strain 2 guinea pigs. This histocom- 
patibility specificity was  not  detected in guinea pigs unable  to respond im- 
munologically to DNP-PLL. The result suggests  that  the poly-L-lysine spe- 
cific immune response gene is very closely linked or even identical with a gene 
determining a major histocompatibility antigen in guinea pigs. 
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